The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Select Comorbid Medical Conditions
The DOI matches its Crossref record; 350 of the 350 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Medical comorbidity in patients with mood disorders has become an increasingly important clinical and global public health issue. Several specific medical conditions are associated with an increased risk of mood disorders, and conversely, mood disorders are associated with increased morbidity and mortality in patients with specific medical disorders. METHODS: To help understand the bidirectional relationship and to provide an evidence-based framework to guide the treatment of mood disorders that are comorbid with medical illness, we have reviewed relevant articles and reviews published in English-language databases (to April 2011) on the links between mood disorders and several common medical conditions, evaluating the efficacy and safety of pharmacologic and psychosocial treatments. The medical disorders most commonly encountered in adult populations (ie, cardiovascular disease, cerebrovascular disease, cancer, human immunodeficiency virus, hepatitis C virus, migraine, multiple sclerosis, epilepsy, and osteoporosis) were chosen as the focus of this review. RESULTS: Emerging evidence suggests that depression comorbid with several medical disorders is treatable and failure to treat depression in medically ill patients may have a negative effect on medical outcomes. CONCLUSIONS: This review summarizes the available evidence and provides treatment recommendations for the management of comorbid depression in medically ill patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with Level 2 Evidence of efficacy for multiple sclerosis and Parkinson's disease”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [25]
In the citing paper
“and Level 3 Evidence for epilepsy and migraines.25,33,34”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [25]
In the citing paper
“there is Level 2 Evidence for treatment of depression with co-occurring cardiovascular disease for CBT, interpersonal therapy (IPT), and problem-solving therapy (PST).25,[27][28][29]”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [25]
In the citing paper
“Level 2 Evidence also exists for a variety of psychological treatments in cancer patients”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [25]
In the citing paper
“for the strikingly high rates of depression accompanying hepatitis C, only Level 3 Evidence exists for psychological treatments”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [25]
Citations
Cites
1 retracted
Psychological treatments for epilepsy
Ramaratnam, S., Baker, G. A., & Goldstein, L. H. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002029.pub3 · Cited by 170
RetractedGrundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Fisher, R. S., Boas, W. V. E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,671
The world health report 2001 - Mental health: new understanding, new hope
Sayers, J. G. (2001) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862001001100014 · Cited by 3,123
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
Ruscio, A. M., Stein, D. J., Chiu, W. T., & Kessler, R. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.94 · Cited by 2,771
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Research works printed but not linked: 22
- AndersonJL, AdamsCD, AntmanEM, ; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116: e148–e304.
- RobinsonRG. Mechanisms of post stroke depression. In: RobinsonRG. The clinical neuropsychiatry of stroke: cognitive, behavioral, and emotional disorders following vascular brain injury. Cambridge, United Kingdom: Cambridge University Press; 1998:254–281.
- JiangB, LuW, SongX-W, . The effect of post stroke depression interventions on the recovery of neurological function. Modern Rehabilitation. 2001;5:29–30. 67.
- LoC, LiM, RodinG. The assessment and treatment of distress in cancer patients: overview and future directions. Minerva Psichiatr. 2008;49:129–143.
- MacleodAD. Methylphenidate in terminal depression. J Pain Symptom Manage. 1998;16:193–198.
- NatenshonAL. Clinical evaluation of Ritalin. Dis Nerv Syst. 1956;17:392–396.
- 10.1037/0022-006x.55.1.42 · doi:10.1037/0022-006x.55.1.42 · Paper page
- 10.1002/(sici)1520-6394(1999)9:2<70::aid-da4>3.0.co;2-l · doi:10.1002/(sici)1520-6394(1999)9:2<70::aid-da4>3.0.co;2-l
- Hepatitis C: global prevalence. Wkly Epidemiol Rec. 1997;72:341–344.
- GleasonOC, YatesWR, PhilipsenMA. Major depressive disorder in hepatitis C: an open-label trial of escitalopram. Prim Care Companion J Clin Psychiatry. 2005;7:225–230.
- ICHD-II. The International Classification of Headache Disorders. 2nd ed. Cephalalgia. 2004;24:8–160. 201.
- SamaanZ, FarmerA. Migraine and depression: connecting the dots. Mind and Brain, The Journal of Psychiatry. 2010;1:55–64.
- LamplC, SchweigerC. Antidepressants for migraine prophylaxis. European Neurological Journal. 2010;2:83–87.
- World Health Organization, Atlas of multiple sclerosis resources in the world 2008. Geneva, Switzerland: World Health Organization; 2008.
- MendezMF, DossRC, TaylorJL, . Depression in epilepsy. Relationship to seizures and anticonvulsant therapy. J Nerv Ment Dis. 1993;181:444–447.
- 10.1002/1531-8249(200002)47:2<246::aid-ana17>3.0.co;2-e · doi:10.1002/1531-8249(200002)47:2<246::aid-ana17>3.0.co;2-e
- SavardG, AndermannLF, ReutensD, . Epilepsy, surgical treatment and postoperative psychiatric complications: a re-evaluation of the evidence. In: TrimbleMR, SchmidtB, eds. Forced normalization and alternative psychosis of epilepsy. Petersfield, United Kingdom: Wrightson Biomedical; 1998:179–192.
- RobertsonMM. Forced normalization and the aetiology of depression in epilepsy. In: TrimbleMR, SchmidtB, eds. Forced normalization and alternative psychosis of epilepsy. Petersfield, United Kingdom: Wrightson Biomedical; 1998:143–167.
- A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group. Neurology. 1995;45:224–230.
- SawkaAM, ThabaneL, PapaioannouA, . The number of Canadian men and women needed to be screened to detect a case of osteoporosis: a population based study from the Canadian Multicentre Osteoporosis Study (CaMos). J Bone Miner Res. 2004;19:S368.
- 10.1001/archinte.1989.00390110045010 · doi:10.1001/archinte.1989.00390110045010 · Paper page
- MeltonLJ3rd, ChrischillesEA, CooperC, . Perspective. How many women have osteoporosis? J Bone Miner Res. 1992;7:1005–1010.
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationVancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015) · World Psychiatry · doi:10.1002/wps.20252 · Cited by 1,271
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Self-citationKennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Self-citationKatzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“In patients with cardiovascular or cerebrovascular comorbidity, it is important to consider the impact of treatments used for anxiety on heart rate, blood pressure, and lipid measures [1443-1445].”
Background
Metadata
- Authors
- Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S.
- Affiliations
- University of Calgary (CA)
- University of Toronto (CA)
- Department of Psychiatry and Behavioural Neurosciences McMaster University Hamilton, Ontario, Canada
- University Health Network (CA)
- Sunnybrook Health Science Centre (CA)
- Douglas Mental Health University Institute (CA)
- Corresponding author
- Ramasubbu, Rajamannar
- ORCID
- Venue
- Annals of Clinical Psychiatry
- Publisher
- SAGE Publications
- Published
- 2012-02
- Volume
- 24
- Issue
- 1
- Pages
- 91-109
- ISSN
- 1040-1237 (ISSN-L)
- 1547-3325
- OpenAlex
- W4414164779
- Semantic Scholar
- c82d6c9a3e306717fddea982a10dfdd3ffc58014
- Cited by
- 206
- References
- 298
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 9 · 2019: 10 · 2018: 20 · 2017: 14 · 2016: 24 · 2015: 29 · 2014: 39 · 2013: 25 · 2012: 14
- FWCI
- 25.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- mood disorders, depression, comorbidities, cardiovascular disease, cerebrovascular disease, cancer, HIV, hepatitis C, migraine, multiple sclerosis, epilepsy, osteoporosis, pharmacotherapy, psychosocial interventions, treatment guidelines
- MeSH terms
- Adult, Antidepressive Agents, Canada, Cardiovascular Diseases, Cerebrovascular Disorders, Chronic Disease, Epilepsy, Hepatitis C, Humans, Migraine Disorders, Multiple Sclerosis, Neoplasms, Osteoporosis, HIV Infections, Comorbidity, Mood Disorders, Advisory Committees
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Select Comorbid Medical Conditions. https://app.cochat.ai/papers/10.1177/104012371202400110
- The paper
- Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012). The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Select Comorbid Medical Conditions. Annals of Clinical Psychiatry. https://doi.org/10.1177/104012371202400110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.